Analgesics - Kenya

  • Kenya
  • In Kenya, the revenue in the Analgesics market is projected to reach US$55.88m by 2024.
  • It is anticipated that the market will experience an annual growth rate of 6.82% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue with US$7,243.00m in 2024.
  • Furthermore, in terms of per person revenues, in Kenya generates US$0.99 in 2024.
  • Kenya's analgesics market is witnessing a surge in demand for locally-produced herbal pain relief remedies.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Kenya has been experiencing significant growth in recent years, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market in Kenya have been shifting towards a greater demand for over-the-counter (OTC) analgesics. This can be attributed to several reasons, including the convenience of purchasing OTC products without a prescription, the increasing awareness and knowledge about self-medication, and the affordability of OTC analgesics compared to prescription medications. Additionally, customers in Kenya have shown a preference for analgesic products that provide quick and effective pain relief, as well as those that have minimal side effects.In terms of market trends, there has been a growing demand for natural and herbal analgesics in Kenya. This trend is driven by the increasing consumer preference for natural and organic products, as well as the perception that natural remedies are safer and have fewer side effects compared to synthetic medications. As a result, many pharmaceutical companies have introduced herbal analgesic products in the market to cater to this demand.Local special circumstances in Kenya have also played a role in the development of the Analgesics market. One such circumstance is the high prevalence of certain diseases and conditions that cause chronic pain, such as arthritis and migraines. This has led to a higher demand for analgesics among the population, as individuals seek relief from their symptoms. Additionally, the availability of analgesics in various forms such as tablets, capsules, creams, and gels has also contributed to the growth of the market, as customers have a wide range of options to choose from based on their preferences and needs.Underlying macroeconomic factors have also influenced the development of the Analgesics market in Kenya. The country's growing population, increasing urbanization, and rising disposable incomes have all contributed to the increased demand for analgesics. As more people move to urban areas and adopt sedentary lifestyles, the prevalence of conditions such as back pain and joint pain has increased, driving the demand for analgesics. Additionally, the rising disposable incomes have made healthcare more affordable for many individuals, allowing them to purchase analgesics as needed.In conclusion, the Analgesics market in Kenya is experiencing growth due to customer preferences for OTC analgesics, the trend towards natural and herbal products, local special circumstances such as the high prevalence of chronic pain conditions, and underlying macroeconomic factors such as population growth and rising disposable incomes. These factors are likely to continue driving the development of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)